JotWe GmbH submitted a voluntary public delisting offer to the shareholders of Geratherm Medical AG on 13 April 2022. Transfer Partners advised the management board and supervisory board of Geratherm Medical AG on the transaction and prepared a fairness opinion.

On 13 April 2022 JotWe GmbH published its decision to submit a voluntary public delisting takeover offer to the shareholders of Geratherm Medical AG in accordance with the German Securities Takeover Act. On 11 May 2022, JotWe offered the shareholders of Geratherm Medical AG a purchase price of EUR 8.50 per share, corresponding to an enterprise value (incl. net financial debt) of EUR 49.1 million. Transfer Partners advised the management board and supervisory board of Geratherm Medical in the context of the transaction and prepared an opinion regarding the financial adequacy of the offer ("fairness opinion").

Geratherm Medical is an internationally oriented medical technology company with the business areas Healthcare Diagnostics, Medical Warming Systems, Cardio / Stroke and Respiratory. The company achieved a turnover of EUR 29.3 million in 2021 and has been listed on the Official Market of the Frankfurt Stock Exchange (Prime Standard) since 2000.